Search results for

Lawmakers heard from two witnesses called by Republicans, former Ukraine peace envoy Kurt Volker and former National Security Council aide Tim Morrison.

NPR's Steve Inskeep speaks with Pam Bondi, special adviser to the president, about the the White House's defense in the Senate trial that could begin next month.

The nation still sees more than 20,000 new cases on average a day, a number that's barely budged for weeks. Forecasters say we're looking at tens of thousands more deaths this summer.

After nearly three weeks of protests, several police departments have already moved to make reforms, but when it comes to sweeping national change, it's not clear how far Washington will go.

Hundreds of towns across the country are wondering what to expect as the coronavirus pandemic effects Memorial Day weekend tourism.

For one family who lost both their mother and their father to the coronavirus, palliative care clinicians helped them face "the awful, awful truth."

Mark Green talks to NPR about what it's like leaving during a global health crisis — and what the future may hold for the agency.

Gilead Sciences, Inc., an American biopharmaceutical company, has published early results of a coronavirus drug trial on Wednesday. NPR science correspondents update on the latest coronavirus news.

Governments worldwide are tracing people with COVID-19 to stop the spread of the virus. NPR's Mary Louise Kelly talks with Massachusetts Gov. Charlie Baker about the state's contact tracing efforts.

While the trip to the battleground state is in part meant to tell a positive story about the administration's response to the pandemic, it also highlights the challenges of the moment.